跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Restime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Restime
Approved
STANDARD
Restime
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
46d25870faafb20d
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
46d25870faafb20d
Drug Approval Philippines Name
Restime
Product Name
Restime
Registration Number
DR-XY35099
Brand Name
Restime
Generic Name
Simeticone
Dosage Form
Chewable Tablet
Dosage Strength
40 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
UNILAB, Inc.
Issuance Date
26 June 2020
Expiry Date
17 September 2025
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
46d25870faafb20d
Type
Standard
Back to Philippines FDA Approvals